Active ingredientAmrubicinCat. No. P-A148-001CAS 110267-81-7Family · Pharmaceutical analytical standards
Amrubicin
An anthracycline that blocks the enzyme topoisomerase II, used against lung cancer, particularly small cell lung cancer; it was first marketed in Japan in 2002. This family brings together the active ingredient and other impurities.
Did you know?It was the first anthracycline made by de novo synthesis, described in 1989: the first anthracyclines, such as daunorubicin discovered in Italy in the early 1960s, were instead extracted from the bacterium Streptomyces peucetius.
Go to the active ingredient →Active ingredientAmrubicinCat. No. P-A148-001CAS 110267-81-7
Active ingredientAmrubicin HClCat. No. P-A148-002CAS 110311-30-3
ImpurityAmrubicinolCat. No. P-A148-003CAS 186353-53-7No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.